United States Pharmaceuticals

Marinus Pharmaceuticals Inc (MRNS)

Track

Ticker: MRNS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Marinus Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 21 Jan 2025
Value US$4,377,067.77 | Price 226.31 | Shares 3,116 (-7.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-23 2025-01-21 PlS Planned sale
Ezickson Elan
Non-Executive Director
3,116 -7.0%
226.31
US$4,377,068 		3,116 -7.0% 226.31 US$4,377,068
2025-01-23 2025-01-21 PlS Planned sale
Johnson Marvin
Non-Executive Director
59,625 +44.6%
358.33
US$3,459,338 		59,625 +44.6% 358.33 US$3,459,338
2024-12-10 2024-12-10 PrS Proposed sale
Saraswathy Nochur

Director

Non-Executive Director
9,916
193.11
US$3,171,946 		9,916 193.11 US$3,171,946
2025-02-11 2024-08-14 PP Planned purchase Braunstein Scott

CHAIRMAN AND CEO

Executive Director
5,933 +2.0%
1.10
US$6,526 		5,933 +2.0% 1.10 US$6,526
2024-08-07 2024-08-05 PlS Planned sale
Braunstein Scott

CHAIRMAN AND CEO

Executive Director
12,145 -3.9%
1.13
US$13,724 		12,145 -3.9% 1.13 US$13,724
2024-08-07 2024-08-05 PlS Planned sale
Hulihan Joseph

CHIEF MEDICAL OFFICER

Officer
4,828 -6.2%
1.13
US$5,456 		4,828 -6.2% 1.13 US$5,456
2024-08-07 2024-08-05 PlS Planned sale
MANNING MARTHA E

SVP, GEN. COUNSEL & CORP. SEC.

Officer
3,621 -5.7%
1.13
US$4,092 		3,621 -5.7% 1.13 US$4,092
2024-08-07 2024-08-05 PlS Planned sale
Shafer Christina

CHIEF COMMERCIAL OFFICER

Officer
3,820 -5.4%
1.14
US$4,355 		3,820 -5.4% 1.14 US$4,355
2024-08-07 2024-08-05 PlS Planned sale
1.4
Pfanstiel Steven

CFO AND COO

Officer
4,657 -5.5%
1.13
US$5,262 		4,657 -5.5% 1.13 US$5,262
2024-02-22 2024-02-20 PlS Planned sale
MANNING MARTHA E

SVP, GEN. COUNSEL & CORP. SEC.

Officer
1,894 -3.5%
9.57
US$18,126 		1,894 -3.5% 9.57 US$18,126
2024-02-22 2024-02-20 PlS Planned sale
Shafer Christina

CHIEF COMMERCIAL OFFICER

Officer
2,153 -3.4%
9.56
US$20,583 		2,153 -3.4% 9.56 US$20,583
2024-02-21 2024-02-16 PlS Planned sale
1.4
Pfanstiel Steven

CFO AND COO

Officer
3,092 -4.1%
9.97
US$30,827 		3,092 -4.1% 9.97 US$30,827
2024-02-21 2024-02-16 PlS Planned sale
Hulihan Joseph

CHIEF MEDICAL OFFICER

Officer
2,814 -4.1%
9.98
US$28,084 		2,814 -4.1% 9.98 US$28,084
2024-02-21 2024-02-16 PlS Planned sale
Braunstein Scott

CHAIRMAN AND CEO

Executive Director
11,850 -5.0%
9.94
US$117,789 		11,850 -5.0% 9.94 US$117,789
2023-08-08 2023-08-08 PlS Planned sale
Shafer Christina

CHIEF COMMERCIAL OFFICER

Officer
11 -0.0%
8.93
US$98 		11 -0.0% 8.93 US$98
2023-08-08 2023-08-08 PlS Planned sale
Braunstein Scott

CHAIRMAN AND CEO

Executive Director
30 -0.0%
8.94
US$268 		30 -0.0% 8.94 US$268
2023-08-08 2023-08-08 PlS Planned sale
1.4
Pfanstiel Steven

CFO AND COO

Officer
14 -0.0%
8.93
US$125 		14 -0.0% 8.93 US$125
2023-08-08 2023-08-08 PlS Planned sale
Hulihan Joseph

CHIEF MEDICAL OFFICER

Officer
13 -0.0%
8.93
US$116 		13 -0.0% 8.93 US$116
2023-08-08 2023-08-08 PlS Planned sale
MANNING MARTHA E

SVP, GEN. COUNSEL & CORP. SEC.

Officer
11 -0.0%
8.93
US$98 		11 -0.0% 8.93 US$98
2023-08-08 2023-08-07 PlS Planned sale
Shafer Christina

CHIEF COMMERCIAL OFFICER

Officer
2,385 -5.5%
9.52
US$22,705 		2,385 -5.5% 9.52 US$22,705
2023-08-08 2023-08-07 PlS Planned sale
Braunstein Scott

CHAIRMAN AND CEO

Executive Director
6,413 -3.8%
9.55
US$61,244 		6,413 -3.8% 9.55 US$61,244
2023-08-08 2023-08-07 PlS Planned sale
1.4
Pfanstiel Steven

CFO AND COO

Officer
2,790 -5.4%
9.54
US$26,617 		2,790 -5.4% 9.54 US$26,617
2023-08-08 2023-08-07 PlS Planned sale
Hulihan Joseph

CHIEF MEDICAL OFFICER

Officer
2,889 -5.7%
9.55
US$27,590 		2,889 -5.7% 9.55 US$27,590
2023-08-08 2023-08-07 PlS Planned sale
MANNING MARTHA E

SVP, GEN. COUNSEL & CORP. SEC.

Officer
2,169 -6.2%
9.54
US$20,692 		2,169 -6.2% 9.54 US$20,692
2023-02-08 2023-02-06 PlS Planned sale
Fischer Seth H. Z.
Non-Executive Director
1,018 -14.5%
6.54
US$6,658 		1,018 -14.5% 6.54 US$6,658
2023-02-08 2023-02-06 PlS Planned sale
Ezickson Elan
Non-Executive Director
750 -11.8%
6.56
US$4,920 		750 -11.8% 6.56 US$4,920
2023-02-08 2023-02-06 PlS Planned sale
Austin Charles
Non-Executive Director
1,073 -16.9%
6.49
US$6,964 		1,073 -16.9% 6.49 US$6,964
2021-03-16 2021-03-15 S Sale
2.6
VITULLO NICOLE
Non-Executive Director
4,250 -100.0%
15.87
US$67,448 		4,250 -100.0% 15.87 US$67,448
2021-03-11 2021-03-09 PlS Planned sale
1.1
Smith Edward F

Former VP, CFO & Treasurer

Officer
40,356 -75.2%
17.80
US$718,337 		40,356 -75.2% 17.80 US$718,337
2020-02-03 2020-01-30 S Sale
1.1
Smith Edward F

CFO
2,380 -11.8%
2.05
US$4,879 		2,380 -11.8% 2.05 US$4,879
2019-12-13 2019-12-13 B Purchase
Braunstein Scott

Chief Executive Officer

Executive Director
100,000 +inf%
1.25
US$125,000 		100,000 +inf% 1.25 US$125,000
2019-05-20 2019-05-16 PlS Planned sale
1.1
Smith Edward F

CFO

Officer
24,211 -54.6%
5.03
US$121,781 		24,211 -54.6% 5.03 US$121,781
2019-01-30 2019-01-29 S Sale
1.1
Smith Edward F

CFO

Officer
2,492 -5.3%
3.06
US$7,626 		2,492 -5.3% 3.06 US$7,626
2019-01-30 2019-01-28 S Sale
0.5
Cashman Christopher Michael

CEO

Executive Director
8,142 -3.3%
3.13
US$25,484 		8,142 -3.3% 3.13 US$25,484
2018-01-29 2018-01-29 S Sale Smith Edward F

CFO

Officer
3,000 -5.7%
7.91
US$23,730 		3,000 -5.7% 7.91 US$23,730
2018-01-22 2018-01-18 S Sale Cashman Christopher Michael

CEO

Executive Director
9,566 -3.7%
6.28
US$60,074 		9,566 -3.7% 6.28 US$60,074
2017-12-19 2017-12-19 S Sale Bain Capital Life Sciences Investors, LLC Large shareholder
55,229 -1.4%
7.11
US$392,430 		55,229 -1.4% 7.11 US$392,430
2017-12-19 2017-12-19 S Sale Bain Capital Life Sciences Investors, LLC Large shareholder
94,771 -2.3%
7.62
US$722,240 		94,771 -2.3% 7.62 US$722,240
2017-12-19 2017-12-18 S Sale Bain Capital Life Sciences Investors, LLC Large shareholder
300,000 -6.8%
7.50
US$2,251,440 		300,000 -6.8% 7.50 US$2,251,440
2017-12-19 2017-12-15 S Sale Bain Capital Life Sciences Investors, LLC Large shareholder
102,882 -2.3%
8.64
US$888,489 		102,882 -2.3% 8.64 US$888,489
2017-12-19 2017-12-15 S Sale Bain Capital Life Sciences Investors, LLC Large shareholder
719,665 -13.7%
8.02
US$5,770,202 		719,665 -13.7% 8.02 US$5,770,202
2016-10-24 2016-10-20 S Sale
1.6
Mehra Anand
Large shareholder
12,528 -44.7%
1.39
US$17,401 		12,528 -44.7% 1.39 US$17,401
2016-10-24 2016-10-20 S Sale
1.6
Mehra Anand
Large shareholder
13,367 -5.6%
1.39
US$18,567 		13,367 -5.6% 1.39 US$18,567
2016-10-24 2016-10-20 S Sale
1.6
Mehra Anand
Large shareholder
724,788 -39.0%
1.39
US$1,006,731 		724,788 -39.0% 1.39 US$1,006,731
2016-08-09 2016-08-08 S Sale Canaan VII LP Large shareholder
19,950 -1.1%
1.50
US$29,925 		19,950 -1.1% 1.50 US$29,925
2016-08-09 2016-08-05 S Sale Canaan VII LP Large shareholder
129,204 -6.5%
1.50
US$193,806 		129,204 -6.5% 1.50 US$193,806
2016-08-05 2016-08-04 S Sale Canaan VII LP Large shareholder
3,329 -0.2%
1.50
US$4,994 		3,329 -0.2% 1.50 US$4,994
2016-08-05 2016-08-03 S Sale Canaan VII LP Large shareholder
142,254 -6.6%
1.50
US$213,381 		142,254 -6.6% 1.50 US$213,381
2016-08-02 2016-07-29 S Sale Canaan VII LP Large shareholder
24,540 -1.1%
1.71
US$41,963 		24,540 -1.1% 1.71 US$41,963
2016-07-27 2016-07-27 S Sale Canaan VII LP Large shareholder
209 -0.0%
1.80
US$376 		209 -0.0% 1.80 US$376
2016-07-27 2016-07-26 S Sale Canaan VII LP Large shareholder
20,380 -0.9%
1.81
US$36,888 		20,380 -0.9% 1.81 US$36,888
2016-07-26 2016-07-25 S Sale Canaan VII LP Large shareholder
137,617 -5.9%
1.86
US$255,968 		137,617 -5.9% 1.86 US$255,968
2016-07-26 2016-07-22 S Sale Canaan VII LP Large shareholder
133,133 -5.4%
1.94
US$258,278 		133,133 -5.4% 1.94 US$258,278
2016-02-11 2015-11-06 B Purchase Cashman Christopher Michael

President and CEO

Executive Director
3,561 +3.2%
5.61
US$19,977 		3,561 +3.2% 5.61 US$19,977
2015-04-23 2015-04-21 PlS Planned sale
3.7
Farfel Gail M

Chief Clinical Dev & Reg Offic

Officer
30,000 -100.0%
9.48
US$284,511 		30,000 -100.0% 9.48 US$284,511
2014-08-07 2014-08-05 B Purchase
1.6
Mehra Anand
Non-Executive Director Large shareholder
12,528 +81.0%
8.00
US$100,224 		12,528 +81.0% 8.00 US$100,224
2014-08-07 2014-08-05 B Purchase
1.6
Mehra Anand
Non-Executive Director Large shareholder
13,367 +5.9%
8.00
US$106,936 		13,367 +5.9% 8.00 US$106,936
2014-08-07 2014-08-05 B Purchase
1.6
Mehra Anand
Non-Executive Director Large shareholder
724,788 +63.9%
8.00
US$5,798,304 		724,788 +63.9% 8.00 US$5,798,304
2014-08-07 2014-08-05 B Purchase Domain Partners VI, L.P. Large shareholder
419,744 +20.4%
8.00
US$3,357,952 		419,744 +20.4% 8.00 US$3,357,952
2014-08-06 2014-08-05 B Purchase
0.9
Bloch Stephen M
Non-Executive Director
625,000 +34.0%
8.00
US$5,000,000 		625,000 +34.0% 8.00 US$5,000,000
2014-08-06 2014-08-05 B Purchase Canaan VII L P Non-Executive Director Large shareholder
625,000 +34.0%
8.00
US$5,000,000 		625,000 +34.0% 8.00 US$5,000,000
Explore more

More insider trading research around Marinus Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America